Protective effect of probiotic Limosilactobacillus reuteri DSM17938 against western diet-induced obesity and associated metabolic alterations
Journal of Functional Foods · 2023-10 · 109 · 105805
DOI: 10.1016/j.jff.2023.105805 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Functional Foods, 2023-10. Verfasst von Angela Di Porzio und 9 weiteren Autor:innen. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Università degli Studi di Napoli Federico II.
Abstract (Originalsprache)
To evaluate the possible application of Limosilactobacillus reuteri DSM 17938 as a strategy to prevent Western Diet-induced metabolic alterations and liver dysfunction. Male Wistar rats of 90 days were divided in three groups and fed a control diet (CD), a high fat - high fructose diet alone (WD) or in combination with the administration of 108 CFU of L. reuteri (WD-R) for 8 weeks. Body composition, energy balance and plasma lipid profile were evaluated, together with hepatic glucose homeostasis and insulin sensitivity. Metabolic inflammation was also assessed at a whole-body level and in the liver, together with mitochondrial function and oxidative stress. Rats that received the WD and L. reuteri administration exhibited a lower body lipid gain and a higher protein gain, underlying a beneficial effect of the probiotic in counteracting the development of obesity. Moreover, the WD-R rats were protected from the development of inflammation at a whole body and liver level and displayed normal glucose homeostasis and insulin sensitivity, a decreased hepatic lipid deposition and a preserved function of the mitochondrial respiratory chain and redox balance. We demonstrate for the first time that Limosilactobacillus reuteri DSM 17938 has a strong efficacy in preventing the development of the hepatic metabolic derangement elicited by the Western diet administration. These are promising results that open the way for the use of this probiotic as a prevention strategy against the development of diet-related diseases, such as type two diabetes and metabolic syndrome.
Förderung
- Università degli Studi di Napoli Federico II
Zitieren
APA
Porzio, A. D., Barrella, V., Gatto, C., Cigliano, L., Spagnuolo, M. S., Crescenzo, R., Romano, I., Mauriello, G., Iossa, S., & Mazzoli, A. (2023). Protective effect of probiotic Limosilactobacillus reuteri DSM17938 against western diet-induced obesity and associated metabolic alterations. Journal of Functional Foods, 109, 105805. https://doi.org/10.1016/j.jff.2023.105805
Vancouver
Porzio AD, Barrella V, Gatto C, Cigliano L, Spagnuolo MS, Crescenzo R, et al. Protective effect of probiotic Limosilactobacillus reuteri DSM17938 against western diet-induced obesity and associated metabolic alterations. Journal of Functional Foods. 2023;109:105805. doi:10.1016/j.jff.2023.105805
BibTeX
@article{Porzio2023,
author = {Porzio, Angela Di and Barrella, Valentina and Gatto, Cristina and Cigliano, Luisa and Spagnuolo, Maria Stefania and Crescenzo, Raffaella and Romano, Ida and Mauriello, Gianluigi and Iossa, Susanna and Mazzoli, Arianna},
title = {Protective effect of probiotic Limosilactobacillus reuteri DSM17938 against western diet-induced obesity and associated metabolic alterations},
journal = {Journal of Functional Foods},
year = {2023},
volume = {109},
pages = {105805},
doi = {10.1016/j.jff.2023.105805}
}
EUVIMED